Just a moment...
We've upgraded AI Search on TaxTMI with two powerful modes:
1. Basic
• Quick overview summary answering your query with references
• Category-wise results to explore all relevant documents on TaxTMI
2. Advanced
• Includes everything in Basic
• Detailed report covering:
- Overview Summary
- Governing Provisions [Acts, Notifications, Circulars]
- Relevant Case Laws
- Tariff / Classification / HSN
- Expert views from TaxTMI
- Practical Guidance with immediate steps and dispute strategy
• Also highlights how each document is relevant to your query, helping you quickly understand key insights without reading the full text.
Help Us Improve - by giving the rating with each AI Result:
Powered by Weblekha - Building Scalable Websites
Press 'Enter' to add multiple search terms. Rules for Better Search
Use comma for multiple locations.
---------------- For section wise search only -----------------
Accuracy Level ~ 90%
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
Don't have an account? Register Here
Press 'Enter' after typing page number.
1. ISSUES PRESENTED AND CONSIDERED
1.1 Whether the power under Section 16(1)(a) of the Companies Act, 2013 can be exercised solely on the ground that the name of a company is identical with or too nearly resembles the name of a pre-existing company, independent of trademark rights or likelihood of deception/confusion.
1.2 Whether, on the admitted facts, the names of the two companies in question are so similar as to attract Section 16(1)(a) of the Companies Act, 2013.
1.3 Whether the Regional Director exceeded his jurisdiction under Section 16(1)(a) by proceeding on considerations akin to trademark infringement or passing off, in light of the decisions in cGMP Pharmaplan and Panchhi Petha Store, and whether such alleged excess vitiates the impugned order.
1.4 Whether the impugned order suffers from perversity or jurisdictional error warranting interference by the High Court under Article 226 of the Constitution of India.
2. ISSUE-WISE DETAILED ANALYSIS
Issue 1: Scope and nature of power under Section 16(1)(a) of the Companies Act, 2013
Legal framework
2.1 Section 16(1)(a) of the Companies Act, 2013 empowers the Central Government to direct a company to change its name where, in its opinion, the name is identical with or too nearly resembles the name of a company previously registered, and mandates compliance within three months by ordinary resolution.
Interpretation and reasoning
2.2 The Court holds that Section 16(1)(a) is not confined to claims of trademark infringement. It is sufficient that the name of the later company is identical with, or closely resembles, that of a pre-existing company.
2.3 The Court notes that Section 16(1)(b) specially deals with applications by proprietors of registered trademarks, but this does not limit or condition the independent operation of Section 16(1)(a), which is concerned with similarity of company names as such.
2.4 Relying on the reasoning in cGMP Pharmaplan (under the pari materia Section 22 of the Companies Act, 1956), the Court reiterates that the jurisdiction under such a provision is wider than that in a trademark or passing off action: it is enough to examine whether one registered name too nearly resembles another registered name; there is no need to examine likelihood of deception or confusion.
Conclusions
2.5 The Court concludes that Section 16(1)(a) can be invoked purely on the ground that the name of a company is identical with or too nearly resembles the name of a pre-existing company, without needing to establish trademark infringement, ownership of trademark rights, or likelihood of deception/confusion.
Issue 2: Applicability of Section 16(1)(a) to the facts and similarity of the two company names
Interpretation and reasoning
2.6 The Court records the undisputed facts: the earlier company was incorporated in 2008, its name subsequently changed to include "Insurance Surveyors and Loss Assessors", and the director who later founded the petitioner-company had been a director of the earlier company for over 13 years, ceasing about two months before incorporation of the petitioner-company. Both companies are engaged in the same line of business as insurance surveyors and loss assessors.
2.7 The Court observes that the two company names are identical in all respects except for the first word: "SKA" in the petitioner's name and "SKAAD" in the earlier company's name. On this basis, the Court finds the names to be "substantially identical".
2.8 The Court further notes the Regional Director's reliance on the undisputed circumstance that certain payments due to the petitioner were inadvertently credited by an insurance company to the bank account of the earlier company, which reinforces the practical similarity/confusability of the names.
Conclusions
2.9 The Court holds that, on the admitted facts, the names of the two companies are substantially identical and too closely resemble each other within the meaning of Section 16(1)(a). The jurisdiction to direct a change of name was, therefore, validly attracted.
Issue 3: Alleged excess of jurisdiction by the Regional Director and relevance of trademark considerations and cited precedents
Interpretation and reasoning
2.10 The petitioner argued that the Regional Director exceeded his jurisdiction by purporting to protect trademark rights in "SKAAD", despite the abandonment/non-progression of the trademark application, and by using language of "infringing the rights" and "confusion in the minds of general public", thereby travelling into the domain of trademark infringement and passing off. Reliance was placed on cGMP Pharmaplan and Panchhi Petha Store.
2.11 The Court rejects this contention as misconceived, holding that the Regional Director's power under Section 16(1)(a) is not limited to trademark-based claims and can be exercised wherever there is identity or close resemblance of company names.
2.12 As to cGMP Pharmaplan, the Court notes that the earlier decision under Section 22 of the 1956 Act (pari materia with Section 16(1)(a)) explicitly recognised that the Central Government's powers in name-rectification proceedings are wider than in trademark disputes. It held that the primary inquiry is whether the names "too nearly resemble" each other, independent of detailed trademark analysis or proof of deception/confusion. The present case is found closer to that precedent, which in fact supports the respondent's position.
2.13 Regarding Panchhi Petha Store, the Court notes that the earlier decision interfered because the Regional Director in that case had returned a finding on ownership of the trademark and then ordered a change of name. In contrast, in the present case, the impugned order is justified solely on the ground of similarity of company names as contemplated by Section 16(1)(a), and is not to be read as a determination of trademark ownership or passing off.
2.14 The Court explicitly clarifies that the impugned order is not to be construed as returning a finding on trademark rights or passing off, but only as a rectification order based on similarity of names under Section 16(1)(a).
Conclusions
2.15 The Court concludes that the Regional Director did not exceed his jurisdiction. Any reference to "infringing the rights" or "confusion" does not convert the proceedings into a trademark or passing off adjudication and does not vitiate the order, which is legally sustainable on the independent ground of similarity of company names under Section 16(1)(a).
Issue 4: Interference under Article 226 of the Constitution
Interpretation and reasoning
2.16 The Court considers whether the impugned order of the Regional Director suffers from such perversity or jurisdictional error as would justify exercise of writ jurisdiction.
2.17 Having found that: (i) Section 16(1)(a) applies; (ii) the names are substantially identical; (iii) the relevant factual circumstances are undisputed; and (iv) the Regional Director acted within his statutory jurisdiction, the Court holds that there is no perversity in the conclusion warranting interference.
Conclusions
2.18 The Court declines to exercise jurisdiction under Article 226 and dismisses the writ petition and pending applications, while extending, at counsel's request, the time for compliance with the Regional Director's order by a further period of one month.